Omeros Stock

Omeros ROE

The Return on Equity (ROE) of Omeros (OMER) as of Aug 21, 2026 is 2.76 %. In the previous year, Return on Equity (ROE) was 85.87 % — a change of -96.78% (lower).

ROE

2.76 %

YoY

-96.78%

Last updated:

In 2026, Omeros's return on equity (ROE) was 2.76 %, a -96.78% increase from the 85.87 % ROE in the previous year.

Access this data via the Eulerpool API

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

ROE Details

Decoding Omeros's Return on Equity (ROE)

Omeros's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Omeros's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Omeros's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Omeros’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Omeros stock

Return on Equity (ROE) of Omeros is 2.76 % in 2026.

Return on Equity (ROE) of Omeros changed from 85.87 % to 2.76 %, representing a -96.78% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Omeros since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Omeros with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — Omeros

All Key Metrics — Omeros